BOZZATO, DANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.460
AS - Asia 1.170
EU - Europa 878
SA - Sud America 23
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 15
OC - Oceania 1
Totale 7.563
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.439
CN - Cina 558
SG - Singapore 438
FI - Finlandia 167
SE - Svezia 155
IT - Italia 152
DE - Germania 111
VN - Vietnam 79
FR - Francia 66
RU - Federazione Russa 61
GB - Regno Unito 56
HK - Hong Kong 40
UA - Ucraina 39
IN - India 21
CA - Canada 19
NL - Olanda 19
BR - Brasile 18
EU - Europa 16
KR - Corea 12
ES - Italia 8
GR - Grecia 8
IE - Irlanda 8
CI - Costa d'Avorio 7
EG - Egitto 7
IQ - Iraq 6
RO - Romania 6
AT - Austria 5
JP - Giappone 5
SI - Slovenia 5
BE - Belgio 4
AR - Argentina 3
LT - Lituania 3
TR - Turchia 3
CL - Cile 2
ID - Indonesia 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
IL - Israele 1
IR - Iran 1
MA - Marocco 1
MX - Messico 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
TW - Taiwan 1
Totale 7.563
Salva come PNG Salva come JPEG
Città #
Woodbridge 621
Chandler 553
Ann Arbor 550
Fairfield 542
Houston 505
Ashburn 360
Singapore 245
Cambridge 217
Wilmington 212
Seattle 191
Jacksonville 158
Boardman 155
Santa Clara 118
Des Moines 117
Princeton 114
Medford 103
Beijing 99
Dong Ket 79
Helsinki 74
Nanjing 74
Roxbury 57
San Diego 54
Padova 53
Hong Kong 33
Jinan 29
Shenyang 27
Hebei 23
Nanchang 22
Guangzhou 19
Los Angeles 18
Tianjin 18
Changsha 17
Zhengzhou 17
Jiaxing 16
London 14
New York 14
Munich 12
Nowon-gu 12
Falkenstein 10
Shanghai 10
Taizhou 10
Kunming 9
Lanzhou 9
Dublin 8
Abidjan 7
Cairo 7
Casier 7
Hefei 7
Milan 7
Norwalk 7
Nuremberg 7
Pune 7
Toronto 7
Washington 7
Amsterdam 6
Falls Church 6
Kowloon City 6
Redwood City 6
Borås 5
Dallas 5
Haikou 5
Hangzhou 5
Harringay 5
Indiana 5
Bologna 4
Brussels 4
Chengdu 4
Frankfurt am Main 4
Indianapolis 4
Legnaro 4
Mahon 4
Mestre 4
Montreal 4
New Delhi 4
Ningbo 4
Taiyuan 4
Dearborn 3
Fuzhou 3
Kharkiv 3
Limena 3
Madrid 3
Ogden 3
Ottawa 3
Phoenix 3
Tappahannock 3
Tokyo 3
Verona 3
Yellow Springs 3
Yenibosna 3
Aprilia 2
Baotou 2
Basra 2
Busto Arsizio 2
Chiyoda-ku 2
Due Carrare 2
Hamburg 2
Hounslow 2
Kilburn 2
Krakow 2
Lappeenranta 2
Totale 5.831
Salva come PNG Salva come JPEG
Nome #
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 170
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 168
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 150
Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability 149
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 141
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 131
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 131
Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis 128
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 127
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 124
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells 119
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 114
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 113
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 111
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 102
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 101
Convergence and cooperativity between EGFR, TGFB, insulin and S100A8/A9 signaling in PDAC 98
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 97
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 93
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 93
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 91
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 91
The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples 88
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 86
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 85
Convergence and cooperativity between EGFR, TGFb, insulin and S100A8/A9 signaling in pancreatic ductal adenocarcinoma (PDAC) 84
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 83
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 81
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 81
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 79
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 79
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 79
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 79
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 78
NT-S100A8 effects on cell signalling. 77
MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers 77
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 76
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 75
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 74
SARS-CoV-2 RNA identification in nasopharyngeal swabs: Issues in pre-analytics 74
Celiac disease diagnosis and monitoring; comparison between chemiluminescence and ELISA anti-transglutaminase and anti-deamidated gliadin peptides measurements. 73
Epidermal growth factor (EGF) chronic stimulation causes Smad4-dependent signaling bypass in PDAC 72
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 72
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 72
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 71
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 71
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 70
Epidermal growth factor (EGF) chronic stimulation causes Smad4- dependent signaling bypass in pancreatic ductal adenocarcinoma (PDAC) 69
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 67
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS 67
Urine protein profiling by maldi-tof/ms: normalization and reproducibility. 67
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 67
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 66
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 66
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 65
Analogs of vitamin e epitomized by α-tocopheryl succinate for pancreatic cancer treatment: In vitro results induce caution for in vivo applications 65
Discovery of new serum biomarkers for pancreatic cancer diagnosis by Maldi-Tof analysis. 64
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 63
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to aquire an immunesuppressive phenotype by downregulating CTLA4. 61
The Inflammatory Molecules S100A8 and TGF-b1 Activate the Epithelial-Mesenchymal Transition Process in Pancreatic Cancer Cells 61
Pancreatic Cancer (PaCa)-Derived Soluble Mediators Induce Dendritic Cells (DC) to Acquire an Immunosuppressive Phenotype by Downregulating CTLA4 59
PANCREATIC CANCER (PaCa)-DERIVED SOLUBLE MEDIATORS INDUCE DENDRITIC CELLS (DC) TO ACQUIRE AN IMMUNESUPPRESSIVE PHENOTYPE BY DOWNREGULATING CTLA4 59
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 59
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 59
Hypo and hyper-glycemia: inflammatory stimuli for circulating monocytes. 58
THE CagL Glu59 POLYMORPHISM OF H. pylori IS ASSOCIATED WITH AN INCREASED RISK OF GASTRIC CANCER. PRELIMINARY RESULTS FROM AN ITALIAN MULTICENTER STUDY 57
S100A8 and S100A9 target AKT, mTOR and NF-KB signalling in pancreatic cancer cells. 56
Hyperglycemia-induced S100A8 and S100A9 expression target ATK, mTOR and NF-KB signalling in pancreatic cancer cells 56
SMAD-4 related and unrelated soluble factors and exosomes co-operate in determining pancreatic adenocarcinoma (PDAC) immunoevasion 56
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 55
Tumor necrosis factor alpha (TNFa) promoter haplotype concurs with HLA-DQA1-DQB1 in determine celiac disease risk. 55
Genome-wide association study identifies an early onset pancreatic cancer risk locus 55
Hyperglycemia-Induced S100A8 and S100A9 Target Akt and NF-kB Signalling in Pancreatic Cancer Cells. 54
Pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (Nt-S100A8). 54
Quality indicators to monitor the rejected outpatients' samples 53
MMP9 and S100A9 Expression in Peripheral Blood Mononuclear Cells (PBMC) Are Correlated with Pancreatic Adenocarcinoma (PDAC) and with PDAC-Associated Diabetes Mellitus 52
Pancreatic Cancer Alters CD4+T Lymphocyte Function: A Piece of the Immunevasion Puzzle 50
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 50
KLK3 and Steroid 5-alpha Reductase TypeII (SRD5A2) gene polymorphisms affect clinical reliability of serum PSA measurement. 50
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 49
Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle. 49
Prostate cancer urine protein profiling by MALDI-TOF/MS: normalization, reproducibility and preliminary results. 48
Associations between pancreatic expression quantitative trait loci (eQTLs) and pancreatic ductal adenocarcinoma risk 48
The CagL GLU59 Polymorphism of H. pylori is associated with an increasedrisk of gastric cancer. Preliminaryresults from an Italian multicenter study. 47
Hypergycemia-induced S100A8 and S100A9 expression target AKT, and NF-KB signalling in pancreatic cancer cells. 47
Hyperglycemia-induced S100A8 and S100A9 target Akt and NF-kB signaling in pancreatic cancer cells. 45
Blood expression of matrix metallo-proteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 45
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 45
Clinical Relevance of Circulating and Splenic Immature Myeloid Cells in Pancreatic Diseases. 44
Aeskulisa and H-TTG/DGP scren for celiac disease diagnosis 44
Erythrocyte sedimentation rate and c-reactive protein in acute inflammation: Meta-analysis of diagnostic accuracy studies 44
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 41
SMAD4 RELATED TRANSFER THROUGH EXOSOMES OF GLYCOLYTIC ENZYMES AND miR-1260 UNDERLIES THE REVERSE WARBURG EFFECT IN PDAC 41
Pancreatic Cancer Alters CD4+T Lymphocyte Function: A Piece of the Immunevasion Puzzle 40
Pancreatic cancer biomarker discovery by SELDI-TOF-MS. 40
Pancreatic Cancer Alters CD4+T Lymphocyte Function: A Piece of the Immunevasion Puzzle 40
The Inflammatory Calcium Binding Protein S100A8 and Its N-Terminal Proteolytic Fragment Interact with Transforming Growth Factor-Beta1 (TGF-b1) and Alter Akt, mTOR and NF-kappa B Cancer Cell Signalling. 39
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 38
The inflammatory molecules S100A8 and TGF-b1 activate the epithelial-mesenchymal transition (EMT) process in pancreatic cancer (PaCa) cells 37
SMAD4 Deletion and EGF Co-Operate in Favoring mTOR Activation in PDAC Cells 36
Totale 7.380
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.799
article - articoli 12.723
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.522
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020416 0 0 0 0 0 0 0 0 103 185 77 51
2020/2021943 26 58 66 115 45 45 34 47 99 133 104 171
2021/2022952 14 182 48 49 43 98 31 75 49 13 65 285
2022/20231.164 206 127 13 131 197 169 4 76 158 9 44 30
2023/2024592 23 70 70 49 46 63 53 65 18 36 40 59
2024/20251.193 14 128 133 121 320 54 118 199 106 0 0 0
Totale 7.636